|
|
|
The lungs can be deceptively accessible to imaging tools, less invasive devices, and
locally acting drugs, but respiratory diseases remain among the most difficult to treat.
The lungs present a fragile environment that cannot always tolerate the mechanical intervention
of instruments or the side effects of drugs. Yet most disease processes such as inflammation,
infection, allergy and fibrosis occur in the lungs and are more difficult to treat. Health Advances'
disease breadth along with device and drug delivery knowledge arms us to develop pragmatic approaches
to address the challenges of diagnosing and treating respiratory conditions.
- Allergic Rhinitis
- Alpha-1 Antitrypsin Deficiency
- Asthma
- Beryllium Disease
- Bronchiectasis
- Bronchitis
- Bronchopulmonary Dysplasia
- COPD, Chronic Bronchitis, Emphysema
- Cystic Fibrosis (CF)
- Granuloma
- Interstitial Lung Disease
- Lung Cancer
- Lung Reduction Surgery
- Pulmonary Arterial Hypertension
- Pulmonary Fibrosis
- Respiratory Syncytial Virus
- Sarcoidosis
- SARS
- Secondary Pulmonary Hypertension
- SIDS
- Stevens-Johnson Syndrome
- Tuberculosis
- Ventilator Acquired Pneumonia (VAP)
|
|
 |
|
|
|
|
|
learn more
about our work with respiratory conditions. |
|
|
|
|
 |
|
|